ProCE Banner Activity

Phase II HALO-202: nab-Paclitaxel and Gemcitabine ± PEGPH20 in Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Slideset Download
Conference Coverage
Addition of PEGPH20 to nab-paclitaxel/gemcitabine improved PFS in the full study population with the greatest improvement in the patients with high tumor levels of hyaluronan.

Released: June 06, 2017

Expiration: June 05, 2018

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants by

AbbVie

Amgen, Inc.

AstraZeneca

Celgene

Genentech Roche Virology

Halozyme

Incyte

Merck Oncology